Accuray CyberKnife® Robotic Radiotherapy Platform Could Significantly Improve Survival in Early-Stage Breast Cancer Patients
Retrieved on:
Monday, October 25, 2021
Safety, Program, Neoplasm, Twitter, U.S. Securities and Exchange Commission, Dalhousie University, Radiation, Survival rate, RWE, NCI, North American Association of Central Cancer Registries, Cyberknife, Erasmus, Incidence, Association, Survival, BEIR, Security (finance), Private Securities Litigation Reform Act, Intelligence, SLC Agrícola, Literature, Pooled analysis, Risk, Panacea Medical Technologies, Real, Synchrony, International Institute for Population Sciences, SLC, Breast cancer, SEC, ABPI, FABS, Surveillance, Erasmus MC, SRP, Population, Frontiers, Technology, LinkedIn, Annual report, Lung, Database, Patient, NASDAQ, YouTube, SEER, Time, Forward-looking statement, Mortality, Medical imaging, Pharmaceutical industry
SUNNYVALE, Calif., Oct. 25, 2021 /PRNewswire/ --Accuray Incorporated(NASDAQ: ARAY) announced today that a study published in Frontiers in Oncology found early-stage breast cancer patients could experience significant improvements in survival if treated with accelerated partial breast irradiation (APBI) delivered using the Accuray CyberKnife robotic radiotherapy platform.
Key Points:
- SUNNYVALE, Calif., Oct. 25, 2021 /PRNewswire/ --Accuray Incorporated(NASDAQ: ARAY) announced today that a study published in Frontiers in Oncology found early-stage breast cancer patients could experience significant improvements in survival if treated with accelerated partial breast irradiation (APBI) delivered using the Accuray CyberKnife robotic radiotherapy platform.
- The addition of radiotherapy can extend survival that may be offset by the development of a secondary cancer like lung tumors many years following treatment.
- This study reinforces the unparalleled accuracy of a 4-like robotic CyberKnife platform and shows its tremendous potential as a treatment for early-stage breast cancer," said Suzanne Winter, president at Accuray.
- Breast cancer stage distribution and number of new cases were obtained from the North American Association of Central Cancer Registries (NAACCR).